|
Boys
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
|
N=
|
555,198
|
557,821
|
560,169
|
561,730
|
563,373
|
565,599
|
568,891
|
571,362
|
573,463
|
575,654
|
576,584
|
|
Alimemazine (R06DA01)
|
8.3
|
7.1
|
7.0
|
7.0
|
5.8
|
5.7
|
6.3
|
5.6
|
4.9
|
4.4
|
4.5
|
|
Hypnotics/sedatives (N05C)
|
4.2
|
5.3
|
6.1
|
7.3
|
7.9
|
8.7
|
9.5
|
10.0
|
10.1
|
10.1
|
10.8
|
|
Stimulants (N06BA)
|
15.0
|
16.9
|
17.5
|
18.7
|
19.7
|
20.5
|
21.0
|
20.8
|
20.7
|
20.6
|
20.8
|
|
Antidepressants (N06A)
|
2.1
|
1.7
|
1.7
|
1.8
|
1.8
|
2.0
|
2.2
|
2.2
|
2.2
|
2.1
|
2.0
|
|
Antipsychotics (N05A)
|
1.6
|
1.8
|
1.9
|
2.0
|
2.2
|
2.3
|
2.3
|
2.4
|
2.3
|
2.2
|
2.2
|
|
Anxiolytics (N05B)
|
4.7
|
4.8
|
4.9
|
4.9
|
4.5
|
4.6
|
4.6
|
4.7
|
4.6
|
4.2
|
3.9
|
|
Total psychotropics
|
30.6
|
30.7
|
31.8
|
33.5
|
33.5
|
35.0
|
37.0
|
36.7
|
35.9
|
34.7
|
35.3
|
|
Girls
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
|
N=
|
527,128
|
530,212
|
532,559
|
534,273
|
535,906
|
537,882
|
540,265
|
543,012
|
544,762
|
547,243
|
548,577
|
|
Alimemazine (R06DA01)
|
7.1
|
6.4
|
6.4
|
6.4
|
5.3
|
4.9
|
5.5
|
5.5
|
5.1
|
4.6
|
4.7
|
|
Hypnotics/sedatives (N05C)
|
2.6
|
3.2
|
3.7
|
4.4
|
5.1
|
5.7
|
6.4
|
7.0
|
7.7
|
8.0
|
8.8
|
|
Stimulants (N06BA)
|
3.8
|
4.9
|
5.5
|
6.3
|
7.0
|
7.4
|
7.9
|
7.9
|
8.1
|
8.3
|
8.5
|
|
Antidepressants (N06A)
|
3.1
|
2.5
|
2.4
|
2.6
|
2.6
|
2.6
|
2.8
|
3.0
|
3.6
|
4.0
|
10.0
|
|
Antipsychotics (N05A)
|
1.1
|
1.1
|
1.1
|
1.1
|
1.1
|
1.1
|
1.1
|
1.2
|
1.5
|
1.5
|
1.6
|
|
Anxiolytics (N05B)
|
4.5
|
4.7
|
4.7
|
4.7
|
4.4
|
4.4
|
4.2
|
4.4
|
4.5
|
4.1
|
3.9
|
|
... Total psychotropics
|
19.2
|
19.0
|
19.7
|
20.9
|
20.7
|
21.1
|
22.9
|
23.6
|
24.5
|
24.2
|
25.0
|
-
aage composition of the overall Norwegian population aged 0–17 years did not change significantly in the period 2004–2014
